Guidant Boosts CHF Resynchronization Therapy R&D With VivoMetrics Deal
This article was originally published in The Gray Sheet
Executive Summary
Guidant looks to use VivoMetrics' LifeShirt ambulatory monitoring system in an upcoming congestive heart failure registry after reaching a purchasing agreement with the firm Dec. 4
You may also be interested in...
Guidant Launches Next Phase Of Heart Failure Registry To Promote ICDs
Guidant is turning from randomized trials to national patient registries to identify underserved heart failure patient groups that can benefit from implantable cardioverter defibrillators
Guidant Launches Next Phase Of Heart Failure Registry To Promote ICDs
Guidant is turning from randomized trials to national patient registries to identify underserved heart failure patient groups that can benefit from implantable cardioverter defibrillators
Guidant COMPANION Results Support Contak CD Mortality Benefit
Guidant's Contak CD cardiac resynchronization therapy pacemaker/ICD demonstrated a 40% reduction in all-cause mortality compared with optimum medical therapy, data from the firm-sponsored COMPANION study show